OrphanDrug
OrphanDrug
Pharma Knowledge Base

xeroderma pigmentosum group F

MeSH: C562592ORPHA: 276264

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

xeroderma pigmentosum characterized by milder symptoms and later onset of skin cancer that has material basis in homozygous or compound heterozygous mutation in the ERCC4 gene on chromosome 16p13

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

MeSH Code

C562592

Orphanet Code

ORPHA:276264
xeroderma pigmentosum group F
MeSHC562592
OrphanetORPHA:276264
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO